DeepCure logo

DeepCure

Reimagining small molecule therapies for immune diseases

28 employees · est. 2018 · Boston, United States

VS
Forward Therapeutics, Inc. logo

Forward Therapeutics, Inc.

Forward, by Design. Novel chemistry. Proven pathways. Designed for patient impact.

12 employees · est. 2022 · Palm Beach Gardens, United S...

DeepCure is the older company (2018 vs 2022).

Side-by-Side Comparison

DeepCure Forward Therapeutics, Inc.
Founded
2018 older 2022
Headquarters
Boston, United States Palm Beach Gardens, United States
Employees
28 12
Industry
AI, Biotechnology, Machine Learning Not tracked yet
Funding Stage
Series A Series A
Total Funding
$64.60M $50.00M
Funding Rounds
5 2
Services
Development of small molecule therapies, Research and development of STAT6 inhibitors, Collaboration with academic and research institutions Development of oral therapies, Advancement of drug candidates, Swift™ Discovery Engine
Target Customers
Pharmaceutical companies, Biotech firms, Healthcare providers, Medical researchers, Patients with immune diseases Patients with inflammation-driven diseases, Pharmaceutical and healthcare partners, Medical and scientific communities
Taxonomy
Small Molecule Therapies, Immune Diseases, Inflammatory Diseases, AI-Driven Drug Discovery, Novel Molecules, Drug Discovery Platform, Oral STAT6 Program, Selective Inhibitors, BRD4(BD2) Program, Precision Therapeutics, Unmet Medical Needs, Chemistry Innovation, Advanced Physics Tools, Immunology Solutions, Pharmaceutical Development Biopharmaceuticals, Clinical-stage, Small Molecule Therapies, Inflammation-driven Diseases, Drug Discovery, Data-driven, Novel Chemistry, SWIFT Drug Discovery Engine, Chronic Inflammatory Disorders, Immune Therapies, Lead Optimization, Screening Assays, Structural Insights
Website
deepcure.com forward-tx.com
DeepCure logo

About DeepCure

DeepCure, founded in 2018 and headquartered in the United States, is innovating the landscape of small molecule therapies specifically targeting immune and inflammatory diseases. The company's slogan, "Reimagining small molecule therapies for immune diseases," encapsulates its mission to introduce g...

Forward Therapeutics, Inc. logo

About Forward Therapeutics, Inc.

Forward Therapeutics, Inc. is a promising United States-based biopharmaceutical company, founded in 2022, that is poised to make significant strides in the treatment of inflammation-driven diseases. With the slogan, "Forward, by Design. Novel chemistry. Proven pathways. Designed for patient impact,"...

We will tell you when either one moves

BounceWatch watches DeepCure and Forward Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at DeepCure and Forward Therapeutics,... — by email.

Frequently Asked Questions

DeepCure — Reimagining small molecule therapies for immune diseases. Forward Therapeutics, Inc. — Forward, by Design. Novel chemistry. Proven pathways. Designed for patient impact.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
DeepCure has raised $64.60M while Forward Therapeutics, Inc. has raised $50.00M.
DeepCure and Forward Therapeutics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare DeepCure with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at DeepCure on 15 Jun 2026, and Forward Therapeutics, Inc. on 23 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy